Zipp, Frauke

Prof. Dr. Zipp is Director of the Clinic and Polyclinic for Neurology at Johannes Gutenberg University Mainz. She has been a board member of the Multiple Sclerosis Competence Network since March 2013 and currently serves as deputy spokesperson.

Since 2009: Director of the Clinic and Polyclinic for Neurology at Johannes Gutenberg University Mainz and member of the Rhine-Main Neuronet (rmn2)2006-2009: Director of the Cecilie Vogt Clinic, Charité Berlin, and Clinical Coordinator at the Max Delbrück Center for Molecular Medicine, Berlin

2002-2006: Director of the Institute of Neuroimmunology, Charité Berlin

1998-2002: Senior physician in neurology, Charité Berlin

1996: Visiting scientist, National Institute of Health in Bethesda, USA

1995-1998: Assistant physician, Neurological Clinic of the Eberhard Karls University of Tübingen

1998: Habilitation, Eberhard Karls University of Tübingen

  • Neuroimmunology (Conference Chair of the International Congress of Neuroimmunology, ISNI)
  • Biomarkers, neurodegeneration, neuroregeneration
  • Genetics (Member of the Steering Committee of the International Multiple Sclerosis Genetics Consortium (IMSGC))
  • Therapy development (BMBF VIP+ validation funding for therapy development; member of the international network PMSA (Progressive Multiple Sclerosis Alliance), project BRAVEinMS “Bioinformatics and cell Reprogramming to develop an in vitro platform to discover new drugs for progessive Multiple Sclerosis”)
  • Council member of the European Society for Treatment and Research in Multiple Sclerosis (ECTRIMS)
  • Executive Board Member of the International Medical and Scientific Board of the International MS Federation with Immunization Commission (MSIF)
  • Founding and co-spokesperson of the Transregional Collaborative Research Center (CRC-TR-128) “Initiation/effector and regulatory mechanisms in multiple sclerosis – from a new understanding of pathogenesis to therapy”
  • Founding member and board member of the German Research Foundation Excellence Initiative “NeuroCure”, Charité – Universitätsmedizin Berlin
  • Founding spokesperson of the Collaborative Research Center (CRC-TR-43) “The brain as a target of inflammatory processes”
  • Board member of the Medical Advisory Board of the German Multiple Sclerosis Society (DMSG)
  • Member of the Research Council of the Rhine-Main Universities
  • Deputy Chairwoman of the Council for Technology of the Government of Rhineland-Palatinate

Mitglied der Nationalen und europäischen Akademie der Wissenschaften
Seit 2011 Leopoldina | Seit 2017 Academia europaea)
Alexander-Karl-Preis (2011)
Heinrich-Pette-Preis (2005)
Lancet-Arbeit erhielt Nils-Ilja-Richter-Preis (2003)
Forschungspreis der DPC-Akademie für klinische Diagnostik (1999)
Langheinrich-Preis (1998)